Archive - September 2019
Mavenclad real-world data shows sustained efficacy
Novartis’ Mayzent could preserve mobility in MS patients
NICE approves BioMarin’s Brineura after initial setback
BMS’ Opdivo shows long-term survival benefit
Scotland and Vertex strike CF drug deal
Gracell reports impressive data with one-day CAR-T for leukaemia
Lucid Group acquires HealthCare21
MSEA 2018 winner shares how the finals day has helped to enhance his area of expertise
